Le Lézard
Classified in: Health
Subject: FEA

Health & Wellness Partners, LLC, Named One of the "Best Places to Work" by MM&M


UPPER SADDLE RIVER, N.J., Dec. 16, 2021 /PRNewswire/ -- Health & Wellness Partners, LLC (HWP), a global medical and scientific communications company, was named an MM+M Best Place to Work 2021. MM+M's panel of judges recognized HWP for its commitment to work-life balance, recognition of employee excellence, effective leadership, and ability to adapt to turbulent times, keeping employees' safety top of mind.

HWP President Jani Hegarty commented, "Being honored by MM&M as one of the best places to work in the life science industry reminds us that our employment experiences are often defined by the culture of the organization. A culture that supports and empowers team members requires focus and commitment. This type of dedication is extremely important to HWP and is a core component of who we are."

MM+M invited agencies to explore what keeps employees truly invested in their work and satisfied with their workplace. MM+M's Best Places to Work initiative invited participating agencies to distribute a link to its survey questionnaire to their employees. After collating the scores, MM+M convened a panel of staff and external judges ? experts in talent recruitment within the medical marketing sector ? to pick the winners. Highlighting some of the most prominent, progressive agencies in the medical marketing industry, the Best Places to Work winners show how successful employers listen to and empower their staff, and help drive the collaboration necessary to take their workplace culture to a whole new level.

Read more here to learn why HWP was selected as an MM+M Best Place to Work.

ABOUT HWP

Founded in 2005 and a certified WBENC enterprise, HWP offers the life-science industry excellence in strategic consulting, tactical planning, enduring materials, live events, digital solutions, and outcomes/metrics. For more information, visit thehwpgroup.com.

Contact: Jani Hegarty, President
Health & Wellness Partners, LLC
[email protected]
(201) 661-5552

SOURCE Health & Wellness Partners


These press releases may also interest you

at 12:36
Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in US
Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of plasma-derived therapeutic products used in treating rare and serious diseases, announced today that...

at 12:28
PANTHERx® Rare Partnering with X4 Pharmaceuticals Inc. for the Distribution of XOLREMDItm (mavorixafor), the First FDA-Approved Therapy Indicated for Use in Patients with WHIM Syndrome
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDItm (mavorixafor), recently approved by the U.S....

at 12:20
Soleo Health Unveils Pharmacy in Jackson, MS; Marks Pharmacy Entry Into State
Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its latest pharmacy and ambulatory infusion center (AIC) in Ridgeland, Mississippi. Soleo Health Jackson offers a broad range of specialty...

at 12:08
Eyemart Express Bolsters 34-Year Legacy with Inflation-Proof Prices
Prices have gone up?and stayed up?since the pandemic, but Eyemart Express has bucked this consumer pricing trend by keeping its prescription eyewear affordable. Since its founding in 1990, the national optical retailer has remained committed to...

at 12:05
Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic...

at 12:05
Managing Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) Found
Pharmaceutical Strategies Group ("PSG"), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability. The...

More news about Health...


News published on and distributed by: